Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.
暂无分享,去创建一个
[1] Wenlei Jiang,et al. Stabilization and Controlled Release of Bovine Serum Albumin Encapsulated in Poly(D, L-lactide) and Poly(ethylene glycol) Microsphere Blends , 2001, Pharmaceutical Research.
[2] R. Mehta,et al. Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption , 1996 .
[3] S. Charm,et al. Shear Degradation of Fibrinogen in the Circulation , 1970, Science.
[4] Wim E. Hennink,et al. Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles , 2000, Pharmaceutical Research.
[5] A. Klibanov,et al. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[6] T. Park,et al. Microencapsulation of dissociable human growth hormone aggregates within poly(D,L-lactic-co-glycolic acid) microparticles for sustained release. , 2001, International journal of pharmaceutics.
[7] T. Park,et al. Stabilization of recombinant interferon-α by pegylation for encapsulation in PLGA microspheres , 2003 .
[8] G. Siber,et al. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. , 1997, Vaccine.
[9] X. Wu,et al. A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic acid) microspheres using agarose hydrogel , 1998 .
[10] A. Göpferich,et al. The effect of poly(ethylene glycol)-poly(D,L-lactic acid) diblock copolymers on peptide acylation. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[11] E. Topp,et al. Solid-state chemical stability of proteins and peptides. , 1999, Journal of pharmaceutical sciences.
[12] J. Gillard,et al. Protein-loaded poly(epsilon-caprolactone) microparticles III. Entrapment of superoxide dismutase by the (water-in-oil)-in water solvent evaporation method , 1999 .
[13] Tae Gwan Park,et al. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres , 1995 .
[14] S J Prestrelski,et al. Precipitation of proteins in supercritical carbon dioxide. , 1996, Journal of pharmaceutical sciences.
[15] B. Gander,et al. Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. , 1995, Journal of microencapsulation.
[16] T. Park,et al. Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. , 2001, Journal of pharmaceutical sciences.
[17] A K Panda,et al. Stabilization of dichloromethane-induced protein denaturation during microencapsulation. , 1998, Pharmaceutical development and technology.
[18] A. Coombes,et al. The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[19] Kai Griebenow,et al. Protein Spray-Freeze Drying. Effect of Atomization Conditions on Particle Size and Stability , 2000, Pharmaceutical Research.
[20] W Wang,et al. Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.
[21] N. Peppas,et al. Preparation of stable insulin-loaded nanospheres of poly(ethylene glycol) macromers and N-isopropyl acrylamide. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[22] M. Wirth,et al. Stabilisation and determination of the biological activity of L-asparaginase in poly(D,L-lactide-co-glycolide) nanospheres. , 2003, International journal of pharmaceutics.
[23] J L Cleland,et al. Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[24] Gerhard Winter,et al. Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients , 1997 .
[25] H. Sah. Protein behavior at the water/methylene chloride interface. , 1999, Journal of pharmaceutical sciences.
[26] T. Park,et al. A new preparation method for protein loaded poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[27] S. Charm,et al. Shear inactivation of heparin. , 1975, Biorheology.
[28] K. Griebenow,et al. Reduction of structural perturbations in bovine serum albumin by non‐aqueous microencapsulation , 2001, The Journal of pharmacy and pharmacology.
[29] R. Ghaderi,et al. Biological Activity of Lysozyme After Entrapment in Poly (d,l-lactide-co-glycolide)-Microspheres , 1997, Pharmaceutical Research.
[30] R. Mehta,et al. Adsorption of peptides to poly(D,L-lactide-co-glycolide): 1. Effect of physical factors on the adsorption , 1996 .
[31] C Vigneron,et al. Preparation and characterization of protein C-loaded PLA nanoparticles. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[32] B. Gander,et al. Enhanced Immunogenicity of Microencapsulated Tetanus Toxoid with Stabilizing Agents , 1998, Pharmaceutical Research.
[33] J. Cleland,et al. The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres , 1997, Pharmaceutical Research.
[34] E. Hundt,et al. Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice , 2001, Pharmaceutical Research.
[35] A. Glomme,et al. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. , 2005, Journal of pharmaceutical sciences.
[36] G. C. Davis. Protein stability: impact upon protein pharmaceuticals. , 1993, Biologicals : journal of the International Association of Biological Standardization.
[37] Smadar Cohen,et al. Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy , 1997 .
[38] G. De Rosa,et al. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[39] T. Park,et al. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. , 1998, Journal of microencapsulation.
[40] P. Debenedetti,et al. Secondary structure characterization of microparticulate insulin powders. , 1994, Journal of pharmaceutical sciences.
[41] K. Griebenow,et al. Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[42] K. Griebenow,et al. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[43] T. Park,et al. Pegylation enhances protein stability during encapsulation in PLGA microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[44] B. Gander,et al. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[45] M. Alonso,et al. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[46] R. Gupta,et al. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen. , 1996, Journal of pharmaceutical sciences.
[47] M. Yeh,et al. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol , 2000, Journal of microencapsulation.
[48] Robert Langer,et al. Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres , 1993, Pharmaceutical Research.
[49] S. Singer. The Properties of Proteins in Nonaqueous Solvents , 1963 .
[50] M Morlock,et al. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[51] M. Alonso,et al. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[52] T. Uchida,et al. Microencapsulation of Hepatitis B Core Antigen for Vaccine Preparation , 1998, Pharmaceutical Research.
[53] Steven P Schwendeman,et al. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. , 2002, Critical reviews in therapeutic drug carrier systems.
[54] K. Griebenow,et al. Encapsulation of bovine serum albumin in poly(lactide‐co‐glycolide) microspheres by the solid‐in‐oil‐in‐water technique , 2001, The Journal of pharmacy and pharmacology.
[55] R. Heeren,et al. Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[56] J. Cleland,et al. Stable Formulations of Recombinant Human Growth Hormone and Interferon-γ for Microencapsulation in Biodegradable Mircospheres , 1996, Pharmaceutical Research.
[57] T. Park,et al. Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. , 1995, PDA journal of pharmaceutical science and technology.
[58] J. Brange,et al. Chemical stability of insulin. 3. Influence of excipients, formulation, and pH. , 1992, Acta pharmaceutica Nordica.
[59] J. Carpenter,et al. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. , 1999, Journal of pharmaceutical sciences.
[60] E. Allémann,et al. Sonication Parameters for the Preparation of Biodegradable Nanocapsulesof Controlled Size by the Double Emulsion Method , 2003, Pharmaceutical development and technology.
[61] M. Alonso,et al. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. , 1999, International journal of pharmaceutics.
[62] W. Tiyaboonchai,et al. Insulin containing polyethylenimine-dextran sulfate nanoparticles. , 2003, International journal of pharmaceutics.
[63] J. O'Shea,et al. The effect of ultrasonic irradiation on proteins. , 1973, Australian journal of biological sciences.
[64] P. G. Shao,et al. Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. , 1999, Pharmaceutical development and technology.
[65] T. Park,et al. Stability and release of bovine serum albumin encapsulated within poly(d,l-lactide-co-glycolide) microparticles , 1996 .
[66] C L Stevenson,et al. Characterization of protein and peptide stability and solubility in non-aqueous solvents. , 2000, Current pharmaceutical biotechnology.
[67] R. Langer,et al. Improved immunogenicity of a core-coated tetanus toxoid delivery system. , 1999, Vaccine.
[68] Y. Yamaguchi,et al. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[69] J. Benoit,et al. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[70] Y. Youn,et al. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[71] M. L. La Rotonda,et al. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[72] L. Meinel,et al. Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[73] Jian Ding,et al. PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers , 2001 .
[74] R. Borchardt,et al. Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.
[75] J L Cleland,et al. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. , 2001, Journal of pharmaceutical sciences.
[76] J. Benoit,et al. Why Does PEG 400 Co-Encapsulation Improve NGF Stability and Release from PLGA Biodegradable Microspheres? , 1999, Pharmaceutical Research.
[77] M. Morlock,et al. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[78] E. Leo,et al. Protein immobilization in crosslinked alginate microparticles , 2002, Journal of microencapsulation.
[79] X. Li,et al. Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[80] Huub Schellekens,et al. Immunogenicity of rDNA-derived pharmaceuticals. , 2002, Trends in pharmacological sciences.
[81] A. Klibanov,et al. On protein solubility in organic solvent. , 1994, Biotechnology and bioengineering.
[82] V. Préat,et al. Preparation and characterization of alginate microspheres containing a model antigen , 1998 .
[83] Y. Kawashima,et al. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. , 1994, Journal of pharmaceutical sciences.
[84] K. Suslick,et al. The sonochemical hot spot , 1987 .
[85] R. Brown,et al. The inactivation of enzymes by ultrasonic cavitation at 20 kHz , 1973 .
[86] Jagdish Singh,et al. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[87] H. Sah. A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres. , 1997, Journal of pharmaceutical sciences.
[88] Jeffrey L. Cleland,et al. Technical and regulatory hurdles in delivery aspects of macromolecular drugs , 1996 .
[89] Robert Langer,et al. Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres , 1991, Pharmaceutical Research.
[90] S. Schwendeman,et al. Influence of basic salts on stability and release of proteins in injectable poly(lactide-co-glycolide) delivery devices , 1999 .
[91] R. Gupta,et al. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. , 1994, Vaccine.
[92] S. Sharif,et al. A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles , 1995 .
[93] S. W. Kim,et al. In Situ Study of Insulin Aggregation Induced by Water-Organic Solvent Interface , 2001, Pharmaceutical Research.
[94] Jagdish Singh,et al. Lysozyme Stability in Primary Emulsion for PLGA Microsphere Preparation: Effect of Recovery Methods and Stabilizing Excipients , 2002, Pharmaceutical Research.
[95] Y. Yamagata,et al. Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[96] S. Charm,et al. Enzyme inactivation with shearing. , 1970, Biotechnology and bioengineering.
[97] D. Quintanar-Guerrero,et al. Applications of the Ion-Pair Concept to Hydrophilic Substances with Special Emphasis on Peptides , 1997, Pharmaceutical Research.
[98] María J. Alonso,et al. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres , 1997 .
[99] Ge Jiang,et al. Preparation and Characterization of a Composite PLGA and Poly(Acryloyl Hydroxyethyl Starch) Microsphere System for Protein Delivery , 2001, Pharmaceutical Research.
[100] B. Gander,et al. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[101] R. Mehta,et al. Adsorption of Salmon Calcitonin to PLGA Microspheres , 1995, Pharmaceutical Research.
[102] B. C. Thanoo,et al. Preparation, Characterization, and In Vitro Evaluation of 1- and 4-Month Controlled Release Orntide PLA and PLGA Microspheres , 2000, Pharmaceutical development and technology.
[103] S. Schwendeman,et al. Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres. , 2001, Journal of pharmaceutical sciences.
[104] J L Cleland,et al. Emerging protein delivery methods. , 2001, Current opinion in biotechnology.
[105] W J Lin,et al. Characterization of protein-loaded poly(epsilon-caprolactone) microparticles based on a factorial design. , 2001, Journal of microencapsulation.
[106] C. Sturesson,et al. Incorporation of protein in PLG-microspheres with retention of bioactivity. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[107] K. Griebenow,et al. Stabilization of alpha-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[108] L. Jorgensen,et al. Secondary structure alterations in insulin and growth hormone water-in-oil emulsions. , 2003, International journal of pharmaceutics.
[109] Alexander M. Klibanov,et al. On Protein Denaturation in Aqueous−Organic Mixtures but Not in Pure Organic Solvents , 1996 .
[110] Y. Chiu,et al. FDA perspective on peptide formulation and stability issues. , 1998, Journal of pharmaceutical sciences.
[111] K. Griebenow,et al. Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method. , 2002, International journal of pharmaceutics.
[112] M. Alonso,et al. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[113] D. Hochstrasser,et al. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for quantitation and molecular stability assessment of insulin entrapped within PLGA nanoparticles. , 2005, Journal of pharmaceutical sciences.
[114] N. Elvassore,et al. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. , 2001, Journal of pharmaceutical sciences.
[115] W. Hennink,et al. The effect of a water/organic solvent interface on the structural stability of lysozyme. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[116] B. Gander,et al. Improving Stability and Release Kinetics of Microencapsulated Tetanus Toxoid by Co-Encapsulation of Additives , 1998, Pharmaceutical Research.
[117] C Vigneron,et al. Protein C-loaded monomethoxypoly (ethylene oxide)-poly(lactic acid) nanoparticles. , 2001, International journal of pharmaceutics.